TrademarkDir
C-CHANGE
LIVE

Serial Number

76556470

Owner

CEO ROUNDTABLE ON CANCER, INC.

Attorney

Rachel M. Hofstatter

Filing Date

Nov 4, 2003

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

C-CHANGE Trademark

Serial Number: 76556470 • Registration: 3058060

C-CHANGE is a trademark filed by CEO ROUNDTABLE ON CANCER, INC. on November 4, 2003. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CEO ROUNDTABLE ON CANCER, INC. (5 trademarks)

940 NW CARY PARKWAY
CARY, NC 27513

Entity Type: 54

C-CHANGE (2 trademarks)

1634 Eye Street, NW
WASHINGTON, DC 20006

Entity Type: 03

National Dialogue on Cancer (2 trademarks)

1000 Thomas Jefferson St, NW
Washington, DC 200073835

Entity Type: 99

Trademark Details

Filing Date

November 4, 2003

Registration Date

February 7, 2006

Published for Opposition

March 1, 2005

Goods & Services

Educational services, namely, development and dissemination of educational materials of others in the field of research, prevention, detection, treatment and elimination of cancer

Charitable fundraising

Association services, namely promoting the public interest and awareness in cancer research, prevention, detection and clinical trials, access to quality cancer care and state cancer plans

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 7, 2025 REM2
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 29, 2017 ASCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 1, 2017 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Apr 15, 2016 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Apr 15, 2016 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 15, 2016 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 15, 2016 APRE
TEAS SECTION 8 & 9 RECEIVED
Feb 8, 2016 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 7, 2015 REM2
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Feb 22, 2012 NA15
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Feb 22, 2012 NAS8
REGISTERED - SEC. 15 ACKNOWLEDGED
Feb 22, 2012 15AK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Feb 22, 2012 8.OK
TEAS SECTION 15 RECEIVED
Feb 9, 2012 E15R
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 6, 2012 EROP
POST REGISTRATION ACTION MAILED - SEC. 8
Jan 4, 2012 PRA8
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 30, 2011 APRE
REGISTERED - SEC. 8 (6-YR) FILED
Dec 19, 2011 8.AF
REGISTERED - SEC. 8 (6-YR) FILED
Dec 19, 2011 8.AF
PAPER RECEIVED
Dec 19, 2011 MAIL
REGISTERED-PRINCIPAL REGISTER
Feb 7, 2006 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Dec 28, 2005 REGV
ASSIGNED TO LIE
Dec 16, 2005 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 14, 2005 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 14, 2005 SUPC
USE AMENDMENT FILED
Nov 22, 2005 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 22, 2005 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 24, 2005 NOAM
PUBLISHED FOR OPPOSITION
Mar 1, 2005 PUBO
NOTICE OF PUBLICATION
Feb 9, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 10, 2004 PREV
ASSIGNED TO LIE
Nov 10, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 14, 2004 CNSA
AMENDMENT FROM APPLICANT ENTERED
Aug 27, 2004 ACEC
ASSIGNED TO LIE
Aug 27, 2004 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 2004 CRFA
PAPER RECEIVED
Jul 28, 2004 MAIL
NON-FINAL ACTION MAILED
May 14, 2004 CNRT
ASSIGNED TO EXAMINER
May 10, 2004 DOCK
NEW APPLICATION ENTERED
Nov 20, 2003 NWAP

Related Trademarks

More from this Owner

CEO CANCER GOLD STANDARD

CEO CANCER GOLD STANDARD

CEO CANCER GOLD STANDARD EARLY DETECTION RISK REDUCTION QUALITY CARE logo

CEO CANCER GOLD STANDARD EARLY DETECTION RISK REDUCTION QUALITY CARE

CEO CANCER GOLD STANDARD

CEO CANCER GOLD STANDARD

CEO CANCER GOLD STANDARD

CEO CANCER GOLD STANDARD

CEO CANCER GOLD STANDARD, EARLY DETECTION, QUALITY CARE, RISK REDUCTION logo

CEO CANCER GOLD STANDARD, EARLY DETECTION, QUALITY CARE, RISK REDUCTION

CEO CANCER GOLD STANDARD, EARLY DETECTION, QUALITY CARE, RISK REDUCTION logo

CEO CANCER GOLD STANDARD, EARLY DETECTION, QUALITY CARE, RISK REDUCTION